Daniel Prieto-Alhambra

Many individuals face prolonged symptoms after COVID-19, impacting their daily lives.

Drug shortages impact patient care and health systems worldwide.

New study shows PDE5 inhibitors may not reduce Alzheimer’s risk.

Head and neck cancers are increasing, affecting survival and prevalence rates.